Monitoring Cerebral Perfusion Changes after Revascularization in Patients with Moyamoya Disease by Using Arterial Spin-labeling MR Imaging

Purpose: To determine whether arterial spin-labeling (ASL) magnetic resonance (MR) imaging could be used to identify changes in cerebral blood flow (CBF), collateral blood flow, and anastomosis site patency after revascularization in patients with moyamoya disease. Materials and Methods: This retrospective study was conducted in 145 patients with moyamoya disease who underwent middle cerebral artery (MCA)-superficial temporal artery anastomosis. Preoperative, early postoperative, and late postoperative ASL and digital subtraction angiography images were analyzed. In the MCA territory, absolute CBF (hereafter, CBF MCA) and normalized CBF values adjusted to nonanastomosis side (hereafter, nCBF MCA) and to cerebellum (hereafter, nCBF Cbll) were calculated. Collateral grading in the MCA territory was assessed according to Alberta Stroke Program Early CT Score methodology, and anastomosis site patency were also assessed. Changes in CBF were compared by using one-way analysis of variance with Bonferroni correction for multiple comparisons. Intermodality agreement was determined by k statistics. Results: Significant increases in CBF MCA, nCBF MCA, and nCBF Cbll were found after revascularization (preoperative and postoperative values of CBF MCA, 35.2 mL/100 g per minute +/- 7.8 [mean +/- standard deviation] and 51.5 mL/100 g per minute +/- 12.0; nCBF MCA, 0.73 mL/100 g per minute +/- 0.14 and 1.01 mL/100 g per minute +/- 0.18; nCBF Cbll, 0.74 mL/100 g per minute +/- 0.12 and 1.12 mL/100 g per minute +/- 0.16; all P<.001). Agreements for collateral grading and anastomosis patency between ASL MR imaging and digital subtraction angiography were moderate to good, with weighted k values of 0.77 (95% confidence interval: 0.73, 0.81) and 0.57 (95% confidence interval: 0.37, 0.76), respectively. Conclusion: ASL MR imaging can be used to identify perfusion changes in patients with moyamoya disease after revascularization as a noninvasive monitoring tool. (c) RSNA, 2018